SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: dr.praveen who wrote (161)7/31/2006 9:43:24 AM
From: tuck  Read Replies (2) | Respond to of 3027
 
From the S-1:

>>M118 is currently in preclinical development. We intend to file an investigational new drug application, or IND, prior to the end of the first quarter of 2005 and begin Phase I clinical trials shortly thereafter.<<

Only a year and a half behind schedule. They were only a bit behind with the M-Enoxaparin ANDA. I hope this isn't a trend.

Cheers, Tuck